Repligen share price logo

Repligen

NASDAQ: RGEN

Large Cap

$175.80

-4.37

(-2.43%)

as on

Repligen Stock Performance

as on October 28, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $164.88
    $180.00
    downward going graph

    6.21%

    Downside

    2.39%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $100.99
    $198.87
    downward going graph

    42.55%

    Downside

    13.12%

    Upside

    downward going graph

Repligen share price movements today

Previous Close
$180.17
Open
$170.80
Volume
1.9M
Market Cap
$11.4B
Day's Low - High
$164.88 - $180.00
52 Week Low - High
$100.99 - $198.87

Repligen Historical Returns

1 Month Return
-9.42 %
3 Month Return
+ 20.96 %
1 Year Return
+ 15.99 %
3 Year Return
+ 47.01 %
5 Year Return
-39.38 %

Repligen Stock Fundamentals & Key Indicators

Check Repligen market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.4B

EPS (TTM)

-0.21

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.66%

PE Ratio (TTM)

243.47

Industry PE ratio

25.64

PEG Ratio

0.30

EBITDA

98.3M

Revenue (TTM)

805.6M

Profit Margin

51.05%

Return On Equity TTM

-0.56%

Repligen vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Repligen with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$11.4B-39.38%243.4751.05%0.00%
Neutral$35.6B-6.65%24.2561.16%0.97%
StrongBuy$159.6B25.38%53.9667.19%0.00%
Neutral$52.8B-18.89%58.5446.12%2.05%
StrongBuy$45.3BNA39.1725.02%0.00%

Stock Returns calculator for Repligen Stock including INR - Dollar returns

The Repligen stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Repligen investment value today

Current value as on today

₹1,25,051

Returns

₹25,051

(+25.05%)

Returns from Repligen Stock

₹15,986 (+15.99%)

Dollar Impact

₹9,065 (+9.07%)

Analyst Recommendation on Repligen Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for Repligen. Average target price of $201.45

Repligen Share Price Target

Get share price movements and forecasts by analysts on Repligen.

What analysts predicted

12.73%UPSIDE

Target Price

$201.45

Current Price

$175.8

Analyzed by

6 Analysts

High

$225

Target

$201.45

Low

$180

Repligen target price $201.45, a slight upside of 12.73% compared to current price of $175.8. According to 6 analysts rating.

Indian Investors' Interest in Repligen Stock

Search interest for Repligen Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-6% versus previous 30 day period

Repligen Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
158
154
167
169
182
188
197
194
204
209
Gross Profit
73
77
38
90
91
100
93
98
108
-
Operating Income
7
-7
-36
6
13
16
18
17
11
-29
EBITDA
35
25
2
36
48
46
49
32
45
-29
Interest Expense
5
5
5
5
5
27
5
5
-17
-5
Depreciation
21
21
35
23
24
24
24
24
23
-
Income Before Tax
9
-1
-38
7
18
17
19
1
14
-26
Income Tax Expense
3
0
-4
2
3
2
5
-6
9
11
Net Income
5
0
-33
5
14
14
13
8
5
-38
Net Profit Margin
46.17%
50.03%
23.18%
53.65%
49.98%
53.24%
47.21%
50.70%
53.08%
0.00%

Repligen Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
141
194
270
366
670
801
632
634
738
Gross Profit
74
108
138
194
391
455
278
274
347
Operating Income
14
25
40
81
167
224
47
-35
59
EBITDA
24
41
56
98
203
277
145
80
182
Interest Expense
6
6
9
12
12
2
10
22
23
Depreciation
10
15
20
27
38
57
86
86
96
Income Before Tax
7
21
26
59
153
219
56
-27
62
Income Tax Expense
-21
4
4
0
25
33
21
-1
13
Net Income
28
16
21
59
128
185
35
-25
48
Net Profit Margin
52.53%
55.70%
51.15%
53.06%
58.35%
56.85%
44.03%
43.29%
47.09%

Repligen Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
3
0
-33
5
14
14
13
8
5
-38
Operating Cash Flow
42
49
39
15
28
48
25
28
32
43
Investing Cash Flow
-7
-5
-64
-74
-7
-7
-208
-3
-2
63
Financing Cash Flow
-5
-69
1
-5
-10
0
0
-5
-6
14
Change in Cash
28
-25
-26
-60
11
39
-182
16
24
120

Repligen Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
28
16
21
59
128
185
41
-25
48
Operating Cash Flow
17
32
67
62
119
172
113
175
117
Investing Cash Flow
-98
-14
-205
-201
-221
-233
-123
-86
-298
Financing Cash Flow
129
3
484
305
0
-13
248
-82
-15
Change in Cash
51
20
343
179
-113
-80
227
6
-191

Global Institutional Holdings in Repligen

Check out the Institutions with significant holdings in Repligen.

Funds
Holdings
BNY Mellon Investment Funds I
0.34%
Voya Equity Trust
0.32%
Fidelity Advisor Series I
0.32%
AB CAP FUND, INC.
0.31%
iShares
8.85%

Repligen News & Key Events

  • img

    Today's Timeline - 27 October

    Tue, 05:00 PM

    -

    Repligen reports Q3 adjusted EPS of 53c, exceeding consensus of 46c, with record revenue of $209.31M.

    Tue, 05:00 PM

    -

    Repligen narrows FY26 adjusted EPS view to $2.05-$2.09 and raises revenue outlook to $844M-$852M.

Insights on Repligen

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, RGEN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, RGEN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, RGEN stock has moved up by 21.0%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 194.25M → 204.12M (in $), with an average increase of 4.8% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 14.91M → 5.00M (in $), with an average decrease of 29.4% per quarter

About Repligen

Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing. This encompasses Protein A ligands, which serve as the key binding elements within Protein A affinity chromatography resins, as well as specialized cell culture growth factors. In the realm of chromatography, Repligen offers a range of products: Its OPUS line features pre-packed chromatography columns, instrumental in purifying biologics, alongside smaller-scale OPUS columns designed for high-throughput process development screening, viral clearance validation studies, and the scaling-down of chromatography processes. Additionally, the company supplies ELISA test kits and chromatography resins marketed under the CaptivA brand. Repligen also boasts an extensive suite of filtration products. This includes XCell Alternating Tangential Flow systems, which are filtration devices utilized in upstream perfusion and cell culture processing. For downstream applications like biologic drug concentration and formulation, they provide TangenX flat sheet cassettes. Other filtration offerings encompass KrosFlo tangential flow filtration and tangential flow depth filtration systems, Spectra/Por laboratory and process dialysis products, SpectraFlo dynamic dialysis systems, and ProConnex single-use hollow fibers. Furthermore, Repligen addresses process analytics with its slope spectroscopy systems, branded as SoloVPE, FlowVPE, and FlowVPX. Their clientele is broad, consisting of life sciences organizations, biopharmaceutical and diagnostics companies, laboratory researchers, and contract manufacturing organizations. Repligen also collaborates with partners, such as Navigo Proteins GmbH, on the development of various affinity ligands. The corporation was founded in 1981 and maintains its corporate headquarters in Waltham, Massachusetts.
OrganisationRepligen
HeadquartersBuilding 1, Waltham, MA, 02453, US
IndustryMedical - Instruments & Supplies
CEOOlivier Loeillot

Key Management of Repligen

Name

Title

Mr. Jason K. Garland

CFO & Chief Compliance Officer

Mr. James R. Bylund

Chief Operating Officer

Ms. Violetta Hughes

Chief Accounting Officer

Mr. Jacob K. Johnson C.F.A.

Vice President of Investor Relations

Mr. Olivier Loeillot

President, CEO & Director

Mr. Anthony J. Hunt

Advisor

Mr. Ralf Kuriyel

Senior Vice President of Research & Development

Mr. Brian Douglass

Senior VP & Chief Product Officer

Ms. Heather Ems

Chief Information Officer

Mr. George A Scott Jr., J.D., M.B.A.

Senior VP & General Counsel

FAQs

What is Repligen share price today?

Repligen share price today is $175.80 as on at the close of the market. Repligen share today touched a day high of $180.00 and a low of $164.88.

What is the 52 week high and 52 week low for Repligen share?

Repligen share touched a 52 week high of $198.87 on and a 52 week low of $100.99 on . Repligen stock price today i.e. is closed at $175.80,which is 11.60% down from its 52 week high and 74.08% up from its 52 week low.

What is Repligen's market capitalisation today?

Repligen market capitalisation is $0.01T as on .

How to invest in Repligen Stock (RGEN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Repligen on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Repligen Stock (RGEN) from India?

Indian investors can start investing in Repligen (RGEN) shares with as little as ₹95.12000274658203 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.20 in Repligen stock (as per the Rupee-Dollar exchange rate as on ). Based on Repligen share’s latest price of $175.80 as on October 28, 2026 at 8:46 am IST, you will get 0.0569 shares of Repligen. Learn more about fractional shares .

What are the returns that Repligen has given to Indian investors in the last 5 years?

Repligen stock has given -39.38% share price returns and 26.8% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?